Anterior Gradient�2 as a Supervisory Marker for Tumor Vessel Normalization Induced by Anti‑angiogenic Treatment

Oncology Letters - Greece
doi 10.3892/ol.2018.8996
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Apelin as a Marker for Monitoring the Tumor Vessel Normalization Window During Antiangiogenic Therapy

Cancer Science
Cancer ResearchMedicineOncology
2015English

Anti-Tumor Innate Immunity Activated by Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved by Anti-Angiogenic Drugs That Spare VEGF Receptor 2

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Tumor Vessel Normalization After Aerobic Exercise Enhances Chemotherapeutic Efficacy

Oncotarget
Oncology
2016English

EnLIGHTenment of Tumor Vessel Normalization and Immunotherapy in Glioblastoma

Journal of Pathology
Forensic MedicinePathology
2018English

Anti-Angiogenic and Tumor-Suppressive Roles of Candidate Tumor-Suppressor Gene, Fibulin-2, in Nasopharyngeal Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Soluble VEGF Receptor-2 May Be a Predictive Marker of Anti-Angiogenic Therapy With Clinically Available Safe Agents

Oncology Letters
Cancer ResearchOncology
2010English

Anti-Tumor Immune Responses Induced by Radiotherapy: A Review

Fukushima Journal of Medical Sciences
Medicine
2015English

Intermedin: A Novel Regulator for Vascular Remodeling and Tumor Vessel Normalization by Regulating Vascular Endothelial-Cadherin and Extracellular Signal-Regulated Kinase

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy